These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2014254)

  • 21. Immunogenicity of recombinant human adenovirus-human immunodeficiency virus vaccines in chimpanzees.
    Natuk RJ; Lubeck MD; Chanda PK; Chengalvala M; Wade MS; Murthy SC; Wilhelm J; Vernon SK; Dheer SK; Mizutani S
    AIDS Res Hum Retroviruses; 1993 May; 9(5):395-404. PubMed ID: 8318268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody responses of chimpanzees immunized with synthetic peptides corresponding to full-length V3 hypervariable loops of HIV-1 envelope glycoproteins.
    Neurath AR; Jiang S; Strick N; Kolbe H; Kieny MP; Muchmore E; Girard M
    AIDS Res Hum Retroviruses; 1991 Oct; 7(10):813-23. PubMed ID: 1720628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term observation of baboons, rhesus monkeys, and chimpanzees inoculated with HIV and given periodic immunosuppressive treatment.
    Morrow WJ; Homsy J; Eichberg JW; Krowka J; Pan LZ; Gaston I; Legg H; Lerche N; Thomas J; Levy JA
    AIDS Res Hum Retroviruses; 1989 Apr; 5(2):233-45. PubMed ID: 2713168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.
    Forns X; Payette PJ; Ma X; Satterfield W; Eder G; Mushahwar IK; Govindarajan S; Davis HL; Emerson SU; Purcell RH; Bukh J
    Hepatology; 2000 Sep; 32(3):618-25. PubMed ID: 10960458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genital infection of female chimpanzees with human immunodeficiency virus type 1.
    Girard M; Mahoney J; Wei Q; van der Ryst E; Muchmore E; Barré-Sinoussi F; Fultz PN
    AIDS Res Hum Retroviruses; 1998 Oct; 14(15):1357-67. PubMed ID: 9788677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virus load in chimpanzees infected with human immunodeficiency virus type 1: effect of pre-exposure vaccination.
    ten Haaft P; Cornelissen M; Goudsmit J; Koornstra W; Dubbes R; Niphuis H; Peeters M; Thiriart C; Bruck C; Heeney JL
    J Gen Virol; 1995 Apr; 76 ( Pt 4)():1015-20. PubMed ID: 9049351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome.
    Fultz PN; McClure HM; Swenson RB; McGrath CR; Brodie A; Getchell JP; Jensen FC; Anderson DC; Broderson JR; Francis DP
    J Virol; 1986 Apr; 58(1):116-24. PubMed ID: 3005641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlates of protective immunity against HIV-1 infection in immunized chimpanzees.
    Murthy KK; Cobb EK; Rouse SR; Lunceford SM; Johnson DE; Galvan AR
    Immunol Lett; 1996 Jun; 51(1-2):121-4. PubMed ID: 8811355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees.
    Hu SL; Fultz PN; McClure HM; Eichberg JW; Thomas EK; Zarling J; Singhal MC; Kosowski SG; Swenson RB; Anderson DC
    Nature; 1987 Aug 20-26; 328(6132):721-3. PubMed ID: 3475581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of CD4+ T cells in human immunodeficiency virus type 1-infected chimpanzees is associated with increased lymphocyte apoptosis.
    Davis IC; Girard M; Fultz PN
    J Virol; 1998 Jun; 72(6):4623-32. PubMed ID: 9573225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells.
    Quinnan GV; Yu XF; Lewis MG; Zhang PF; Sutter G; Silvera P; Dong M; Choudhary A; Sarkis PT; Bouma P; Zhang Z; Montefiori DC; Vancott TC; Broder CC
    J Virol; 2005 Mar; 79(6):3358-69. PubMed ID: 15731230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzees.
    Robinson WE; Montefiori DC; Mitchell WM; Prince AM; Alter HJ; Dreesman GR; Eichberg JW
    Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4710-4. PubMed ID: 2471977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell-mediated immune proliferative responses to HIV-1 of chimpanzees vaccinated with different vaccinia recombinant viruses.
    Van Eendenburg JP; Yagello M; Girard M; Kieny MP; Lecocq JP; Muchmore E; Fultz PN; Riviere Y; Montagnier L; Gluckman JC
    AIDS Res Hum Retroviruses; 1989 Feb; 5(1):41-50. PubMed ID: 2470398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees.
    Emini EA; Nara PL; Schleif WA; Lewis JA; Davide JP; Lee DR; Kessler J; Conley S; Matsushita S; Putney SD
    J Virol; 1990 Aug; 64(8):3674-8. PubMed ID: 2370678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of HIV infection by passive immunization with HIV immunoglobulin.
    Prince AM; Reesink H; Pascual D; Horowitz B; Hewlett I; Murthy KK; Cobb KE; Eichberg JW
    AIDS Res Hum Retroviruses; 1991 Dec; 7(12):971-3. PubMed ID: 1812946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of a vaccinia-derived recombinant HIV-1 gp160 candidate vaccine and its immunogenicity in chimpanzees.
    Barrett N; Eder G; Dorner F
    Biotechnol Ther; 1991; 2(1-2):91-106. PubMed ID: 1845126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of human immunodeficiency virus replication by CD8+ cells from infected and uninfected chimpanzees.
    Castro BA; Walker CM; Eichberg JW; Levy JA
    Cell Immunol; 1991 Jan; 132(1):246-55. PubMed ID: 1676614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Yeast-expressed p55 precursor core protein of human immunodeficiency virus type 1 does not elicit protective immunity in chimpanzees.
    Emini EA; Schleif WA; Quintero JC; Conard PG; Eichberg JW; Vlasuk GP; Lehman ED; Polokoff MA; Schaeffer TF; Schultz LD
    AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1247-50. PubMed ID: 2127681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV infection of chimpanzees as a model for testing chemotherapeutics.
    Fultz PN; McClure HM; Swenson RB; Anderson DC
    Intervirology; 1989; 30 Suppl 1():51-8. PubMed ID: 2708009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and immunogenicity of a gp120-depleted, inactivated HIV-1 immunogen: results of a double-blind, adjuvant controlled trial.
    Trauger RJ; Daigle AE; Giermakowska W; Moss RB; Jensen F; Carlo DJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 2():S74-82. PubMed ID: 7552517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.